Newsletter
Decodes China's cell & gene therapy policy, pricing, and deals for Western investors and operators.
Your BioNative signal
Updates from what you follow and activity around your own work.
Give your work a permanent home
Show what you made, who it helps, and how people can reach you. We will keep it discoverable while you build what is next.
Help the right people find you
Open only the details that help people discover and understand this work.
The Problem Board post will reuse the problem story, audience, domain, and workflow you entered above—so the two listings stay aligned.
Once approved, your work keeps a searchable home on BioNative. Share it now—or go build the next thing.
Start with the need
Share a real bottleneck. The community may know a build—or make one.
Do not include patient, confidential, or proprietary data.
Save what works together
Curate a practical set of products for one biotech workflow.
Useful collections explain the workflow, not just the products.
Join BioNative
Join free to submit products, upvote useful work, follow founders, and start conversations when the fit is right.
Your founder identity
Add enough context for the right person to recognize a fit. Every field except your display name is optional.
Member-only contact
Email unavailable
Your public profile appears after your first product is approved. Until then, only you can preview it.
Community care
Reports are private and reviewed by a human. A report never changes scientific status by itself.
The author will not see who submitted the report.
Keep your listing current
Show future visitors what changed, whether the product is active, and what kind of conversation would be useful now.
Milestones are progress records, not BioNative validation.